Iwicki Mark T. - 29 Jun 2021 Form 3 Insider Report for Aerovate Therapeutics, Inc. (JBIO)

Role
Director
Signature
/s/ George A. Eldridge, Attorney-in-Fact
Issuer symbol
JBIO
Transactions as of
29 Jun 2021
Net transactions value
$0
Form type
3
Filing time
29 Jun 2021, 19:41:20 UTC
Previous filing
29 Jun 2021
Next filing
28 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AVTE Stock Option (Right to Buy) 29 Jun 2021 Common Stock 39,550 $2.14 Direct F1
holding AVTE Stock Option (Right to Buy) 29 Jun 2021 Common Stock 76,747 $2.14 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable in 48 substantially equal monthly installments, with the first installment vested on March 12, 2021.
F2 This option shall vest and become exercisable in 48 substantially equal monthly installments, with the first installment vesting on July 4, 2021.

Remarks:

Exhibit 24 - Power of Attorney